1. Introduction
Quinazolinones, a group of nitrogen containing heterocyclic compounds, are very prominent medicinal and pharmaceutical scaffolds, showing a wide range of biological activities. Their activities include antibacterial [1,2,3,4], antifungal, antitumor [5,6,7,8], antidiabetic [9,10,11], anti-inflammatory [12,13,14] and many others. Many researchers these days are investigating their synthesis, finding the most efficient synthetic paths and synthesizing different derivatives and hybrids. Our investigation was based on the synthesis of quinazolinone–pyridine hybrids, since pyridine derivatives have also proven to be biologically active [15,16]. Keeping the green chemistry principles in mind [17], we applied a mechanochemical procedure in the synthesis of such hybrids. Since conventional synthetic methods usually have adverse effects on the environment due to the utilization of high volumes of volatile organic solvents [18], high energy consumption and waste production, green synthetic methods are becoming more prominent in recent times [19]. Mechanochemistry, as one of these methods, has found applications in many chemical processes. Mechanochemical reactions can be performed solvent-free and at low temperatures due to the combination of mechanical and chemical phenomena. Reaction times are usually reduced, while the post-synthetic procedures are minimal, with the overall process being faster and cleaner [20].
2. Results and Discussion
A new compound N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide was synthesized from 6-iodo-2-methyl-4H-benzo[d][1,3]oxazin-4-one (1) and pyridine-2,6-dicarbohydrazide (2). First, 6-iodo-2-methyl-4H-benzo[d][1,3]oxazin-4-one (1) was synthesized in a microwave-assisted reaction according to Figure 1, as described in our previous work [21].
Then, pyridine-2,6-dicarbohydrazide (2) was synthesized (Figure 2) according to Molnar et al. [22].
Afterwards, the synthesis of the desired compound was performed mechanochemically, using freshly prepared 6-iodo-2-methyl-4H-benzo[d][1,3]oxazin-4-one (1) and pyridine-2,6-dicarbohydrazide (2) and1 mL of choline chloride:urea (1:2) deep eutectic solvent (DES) (Figure 3). The mixture was ball-milled for 20 min and upon completion of the reaction, water was added to the mixture. The new compound was recrystallized from methanol and obtained with 57% yield. The melting point, NMR and mass spectra were recorded.
The 1H NMR spectra reveal some characteristic peaks. Quinazolinone C-2 methyl protons show singlet peaks at 2.51 ppm, aromatic protons peaks are found at 7.52–8.47 ppm, while –NH- protons are found at 12.24 and 12.15 ppm. The 13C NMR spectra also show peaks characteristic of a –CH3 carbon at 21.8 ppm and characteristic aromatic carbon peaks (full spectra available in Supplementary Materials).
This synthetic pathway has green character due to utilization of DES as a catalyst, which is biodegradable and non-toxic, while ball-milling proves to be time and energy efficient, yielding the final compound in high purity. The synthesis of similar compounds, using benzoxazinone and different amines, is usually performed conventionally, but in most cases requires longer times, higher temperatures or extensive purification [23,24,25,26].
3. Materials and Methods
All chemicals were purchased from commercial suppliers and were used as such. Choline chloride (99%) was purchased from Acros Organics (Geel, Belgium) and urea (p.a.) was purchased from Gram Mol. Aluminum plates coated with silica gel fluorescent indicator F254 (Kieselgel 60) were used for thin-layer chromatography, while benzene: acetone: acetic acid (8:1:1) was used as a mobile phase. TLC plates were monitored using HP-UVIS cabinet (Biostep GmbH, Burkhardtsdorf, Germany). The Electrothermal IA9100 melting point apparatus (Electrothermal Engineering Ltd., Rochford, UK) was used for melting point determination. NMR spectra were recorded on a Bruker 600 MHz spectrometer (Bruker Biospin, Rheinstetten, Germany). Mass spectra were recorded on an LC/MS/MS API 2000 (Foster City, CA, USA). IR spectra were recorded on an Agilent Cary 630 FTIR Spectrometer (Agilent Technologies, Santa Clara, CA, USA). The synthesis was performed using an Omni Bead Ruptor 12 Homogenizer (OMNI International, Kennesaw, GA, USA).
Synthesis of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide.
To a reaction mixture of 6-iodo-2-methyl-4H-benzo[d][1,3]oxazin-4-one (1 mmol, 287.05 mg) and pyridine-2,6-dicarbohydrazide (0.5 mmol, 97.6 mg), 1 mL of ChCl: urea DES and 3 g of ceramic beads was added. The mixture was subjected to ball-milling for 20 min at 6 m/s. The reaction was monitored by TLC (benzene:acetone:acetic acid 8:1:1) and quenched with water. Upon precipitation, the product was filtered off and recrystallized from methanol with 57% yield.
Mp = 249–251 °C; Rf = 0.58; MS (ESI): m/z = 732.10 [M-H]− (Mr = 733.26). 1H NMR (600 MHz, DMSO-d6): δ/ppm 12.24 (1H, s, -NH-); 12.15 (1H, s, -NH-); 8.47–8.38 (5H, m, arom.); 8.22–8.18 (2H, m, arom.); 7.52 (2H, dd, J = 8.6; 1.2 Hz, arom.); 2.51 (6H, s, -CH3). 13C NMR (150 MHz, DMSO-d6): δ/ppm 162.9; 162.8; 158.3; 158.1; 157.3; 147.1; 146.3; 144.2; 141.2; 135.1; 129.8; 127.1; 122.6; 92.7; 21.8.
4. Conclusions
A new derivative of dipicolinic acid was mechanochemically synthesized. The synthesis was performed using benzoxazinone, pyridine-2,6-dicarbohydrazide and choline chloride: urea DES as a catalyst, and was performed in 10 min. Our method for this synthesis is green, efficient and short.
Conceptualization, M.M.; methodology, M.K.; software, M.M. and M.K.; validation, M.M., M.K. and I.J.; formal analysis, M.M.; investigation, M.K.; resources, M.M.; data curation, I.J.; writing—original draft preparation, M.M.; writing—review and editing, M.M. and I.J.; visualization, M.K.; supervision, M.M.; project administration, M.M.; funding acquisition, M.M. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
Not applicable.
We would like to thank the Croatian Science Foundation for funding the project “Green Technologies in Synthesis of Heterocyclic compounds” (UIP-2017-05-6593).
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure 1. Microwave-assisted synthesis of 6-iodo-2-methyl-4H-benzo[d][1,3]oxazin-4-one.
Figure 3. Synthesis of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide.
Supplementary Materials
The following supporting information can be downloaded online, Figure S1: 1H NMR spectra of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide; Figure S2: Mass spectra of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide; Figure S3: 13C NMR spectra of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide; Figure S4: IR spectra of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide; Molfile of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide.
References
1. Sayyed, M.A.; Mokle, S.S.; Vibhute, Y.B. Synthesis of 6-Iodo/Bromo-3-Amino-2-Methylquinazolin-4(3H)-Ones by Direct Halogenation and Their Schiff Base Derivatives. ARKIVOC; 2006; 2006, pp. 221-226. [DOI: https://dx.doi.org/10.3998/ark.5550190.0007.b22]
2. Atia, A.J.K.; Al-Mufrgeiy, S.S. Synthesis and Antibacterial Activities of New 3-Amino-2-Methyl-Quinazolin-4 (3H)-One Derivatives. Am. J. Chem.; 2012; 2, pp. 150-156. [DOI: https://dx.doi.org/10.5923/j.chemistry.20120203.09]
3. Gatadi, S.; Gour, J.; Shukla, M.; Kaul, G.; Das, S.; Dasgupta, A.; Malasala, S.; Borra, R.S.; Madhavi, Y.V.; Chopra, S. et al. Synthesis of 1,2,3-Triazole Linked 4(3H)-Quinazolinones as Potent Antibacterial Agents against Multidrug-Resistant Staphylococcus Aureus. Eur. J. Med. Chem.; 2018; 157, pp. 1056-1067. [DOI: https://dx.doi.org/10.1016/j.ejmech.2018.08.070]
4. Masri, A.; Anwar, A.; Khan, N.A.; Shahbaz, M.S.; Khan, K.M.; Shahabuddin, S.; Siddiqui, R. Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles. Antibiotics; 2019; 8, 179. [DOI: https://dx.doi.org/10.3390/antibiotics8040179] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31600971]
5. Long, S.; Resende, D.I.S.P.; Kijjoa, A.; Silva, A.M.S.; Pina, A.; Fernández-Marcelo, T.; Vasconcelos, M.H.; Sousa, E.; Pinto, M.M.M. Antitumor Activity of Quinazolinone Alkaloids Inspired by Marine Natural Products. Mar. Drugs; 2018; 16, 261. [DOI: https://dx.doi.org/10.3390/md16080261] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30065225]
6. Lai, K.-C.; Chia, Y.-T.; Yih, L.-H.; Lu, Y.-L.; Chang, S.-T.; Hong, Z.-X.; Chen, T.-L.; Hour, M.-J. Antitumor Effects of the Novel Quinazolinone Holu-12: Induction of Mitotic Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma CAL27 Cells. Anticancer Res.; 2021; 41, pp. 259-268. [DOI: https://dx.doi.org/10.21873/anticanres.14772]
7. Wdowiak, P.; Matysiak, J.; Kuszta, P.; Czarnek, K.; Niezabitowska, E.; Baj, T. Quinazoline Derivatives as Potential Therapeutic Agents in Urinary Bladder Cancer Therapy. Front. Chem.; 2021; 9, 765552. [DOI: https://dx.doi.org/10.3389/fchem.2021.765552]
8. Niu, Z.; Ma, S.; Zhang, L.; Liu, Q.; Zhang, S. Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents. Molecules; 2022; 27, 3906. [DOI: https://dx.doi.org/10.3390/molecules27123906]
9. Saeedi, M.; Mohammadi-Khanaposhtani, M.; Pourrabia, P.; Razzaghi, N.; Ghadimi, R.; Imanparast, S.; Faramarzi, M.A.; Bandarian, F.; Esfahani, E.N.; Safavi, M. et al. Design and Synthesis of Novel Quinazolinone-1,2,3-Triazole Hybrids as New Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Docking Study. Bioorg. Chem.; 2019; 83, pp. 161-169. [DOI: https://dx.doi.org/10.1016/j.bioorg.2018.10.023]
10. Khalifa, M.M.; Sakr, H.M.; Ibrahim, A.; Mansour, A.M.; Ayyad, R.R. Design and Synthesis of New Benzylidene-Quinazolinone Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, and Docking Studies. J. Mol. Struct.; 2022; 1250, 131768. [DOI: https://dx.doi.org/10.1016/j.molstruc.2021.131768]
11. Barmak, A.; Niknam, K.; Mohebbi, G. Synthesis, Structural Studies, and α-Glucosidase Inhibitory, Antidiabetic, and Antioxidant Activities of 2,3-Dihydroquinazolin-4(1H)-Ones Derived from Pyrazol-4-Carbaldehyde and Anilines. ACS Omega; 2019; 4, pp. 18087-18099. [DOI: https://dx.doi.org/10.1021/acsomega.9b01906] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31720511]
12. Chaitanya, P.; Reddy, G.D.; Varun, G.; Srikanth, L.M.; Prasad, V.V.S.R.; Ravindernath, A. Design and Synthesis of Quinazolinone Derivatives as Anti-Inflammatory Agents: Pharmacophore Modeling and 3D QSAR Studies. Med. Chem.; 2014; 10, pp. 711-723. [DOI: https://dx.doi.org/10.2174/1573406409666131128142843] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24286396]
13. Krishnarth, N.; Verma, S.K.; Chaudhary, A. Synthesis and Anti-Inflammatory Activity of Some Novel Quinazolinone Derivatives. FABAD J. Pharm. Sci.; 2020; 45, pp. 205-210.
14. Poojari, S.; Krishnamurthy, G.; KS, J.K.; Kumar, S.; Naik, S. Anti-Inflammatory, Antibacterial and Molecular Docking Studies of Novel Spiro-Piperidine Quinazolinone Derivatives. J. Taibah Univ. Sci.; 2017; 11, pp. 497-511. [DOI: https://dx.doi.org/10.1016/j.jtusci.2016.10.003]
15. Altaf, A.A.; Shahzad, A.; Gul, Z.; Rasool, N.; Badshah, A.; Lal, B.; Khan, E. A Review on the Medicinal Importance of Pyridine Derivatives. J. Drug Des. Med. Chem.; 2015; 1, 1. [DOI: https://dx.doi.org/10.11648/j.jddmc.20150101.11]
16. Ling, Y.; Hao, Z.-Y.; Liang, D.; Zhang, C.-L.; Liu, Y.-F.; Wang, Y. The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. Drug Des. Dev. Ther.; 2021; 15, pp. 4289-4338. [DOI: https://dx.doi.org/10.2147/DDDT.S329547]
17. Anastas, P.T.; Warner, J.C. Green Chemistry: Theory and Practice; Oxford University Press: Oxford, UK, 2000; ISBN 978-0-19-850698-0
18. David, E.; Niculescu, V.-C. Volatile Organic Compounds (VOCs) as Environmental Pollutants: Occurrence and Mitigation Using Nanomaterials. Int. J. Environ. Res. Public Health; 2021; 18, 13147. [DOI: https://dx.doi.org/10.3390/ijerph182413147]
19. Bedlovičová, Z. Green Synthesis—An Overview. Green Synthesis of Silver Nanomaterials; Elsevier Inc.: Amsterdam, The Netherlands, 2022; pp. 547-569.
20. Do, J.-L.; Friščić, T. Mechanochemistry: A Force of Synthesis. ACS Cent. Sci.; 2017; 3, pp. 13-19. [DOI: https://dx.doi.org/10.1021/acscentsci.6b00277]
21. Komar, M.; Prašnikar, F.; Kraljević, T.G.; Aladić, K.; Molnar, M. 3-Amino-2-Methylquinazolin-4-(3H)-One Schiff Bases Synthesis—A Green Chemistry Approach—A Comparison of Microwave and Ultrasound Promoted Synthesis with Mechanosynthesis. Curr. Green Chem.; 2021; 8, pp. 62-69. [DOI: https://dx.doi.org/10.2174/2213346107999201231125434]
22. Molnar, M.; Pavić, V.; Šarkanj, B.; Čačić, M.; Vuković, D.; Klenkar, J. Mono- and Bis-Dipicolinic Acid Heterocyclic Derivatives—Thiosemicarbazides, Triazoles, Oxadiazoles and Thiazolidinones as Antifungal and Antioxidant Agents. Heterocycl Commun; 2017; 23, pp. 35-42. [DOI: https://dx.doi.org/10.1515/hc-2016-0078]
23. Ramanathan, M.; Hsu, M.-T.; Liu, S.-T. Preparation of 4(3H)-Quinazolinones from Aryldiazonium Salt, Nitriles and 2-Aminobenzoate via a Cascade Annulation. Tetrahedron; 2019; 75, pp. 791-796. [DOI: https://dx.doi.org/10.1016/j.tet.2018.12.065]
24. Rajput, C.S.; Kumar, A.; Kumar Bhati, S.; Singh, J. Synthesis and Antiinflammatory Activity of 2-[5′-(4-Pyridinyl)-1′,2′,3′-Oxadiazol-2-Yl-Thiomethyl]-3-Substituted-Aryl-6-Substituted-Quinazolin-4-Ones. Asian J. Chem.; 2008; 20, pp. 6246-6252.
25. Marinho, E.; Proença, M.F. The Reaction of 2-(Acylamino)Benzonitriles with Primary Aromatic Amines: A Convenient Synthesis of 2-Substituted 4-(Arylamino)Quinazolines. Synthesis; 2015; 47, pp. 1623-1632. [DOI: https://dx.doi.org/10.1055/s-0034-1380322]
26. Ajani, O.O.; Audu, O.Y.; Germann, M.W.; Bello, B.L. Expeditious Synthesis and Spectroscopic Characterization of 2-Methyl-3-Substituted-Quinazolin-4(3H)-One Derivatives. Orient. J. Chem.; 2017; 33, pp. 562-574. [DOI: https://dx.doi.org/10.13005/ojc/330203]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
A green chemistry method was applied in the synthesis of N2,N6-bis(6-iodo-2-methyl-4-oxoquinazolin-3(4H)-yl)pyridine-2,6-dicarboxamide. The desired compound was synthesized mechanochemically, using a choline chloride-based deep eutectic solvent as a catalyst. The synthesis took 20 min and the new compound was characterized using different spectral methods.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Faculty of Food Technology Osijek, Josip Juraj Strossmayer University of Osijek, Franje Kuhača 18, 31000 Osijek, Croatia;
2 Faculty of Chemistry and Technology, University of Split, R. Boškovića 35, 21000 Split, Croatia